Evidence map›Paper›PMID 32094223›Full record

ArticleThe Journal of biological chemistry2020

Ubiquitination of the scaffold protein IQGAP1 diminishes its interaction with and activation of the Rho GTPase CDC42.

Laëtitia Gorisse, Zhigang Li, Craig D Wagner, David K Worthylake, Francesca Zappacosta, Andrew C Hedman, Roland S Annan, David B Sacks

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Decoding Rho GTPase signalling networks in directed cell migration.Frontiers in cell and developmental biology · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Signaling in the crowded cell.Current opinion in structural biology · 2021
    Review
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Laëtitia GorisseDepartment of Laboratory Medicine, National Institutes of Health, Bethesda, Maryland 20892.
Zhigang LiDepartment of Laboratory Medicine, National Institutes of Health, Bethesda, Maryland 20892.
Craig D WagnerDiscovery Analytical, GlaxoSmithKline, Collegeville, Pennsylvania 19426.
David K WorthylakeDepartment of Biochemistry and Molecular Biology, Louisiana State University Health Sciences, New Orleans, Louisiana 70112.
Francesca ZappacostaDiscovery Analytical, GlaxoSmithKline, Collegeville, Pennsylvania 19426.
Andrew C HedmanDepartment of Laboratory Medicine, National Institutes of Health, Bethesda, Maryland 20892.
Roland S AnnanDiscovery Analytical, GlaxoSmithKline, Collegeville, Pennsylvania 19426.
David B SacksDepartment of Laboratory Medicine, National Institutes of Health, Bethesda, Maryland 20892 david.sacks2@nih.gov.ORCID 0000-0003-3100-0735
National Institutes of Health · USGlaxoSmithKline (United States) · USLouisiana State University Health Sciences Center New Orleans · US

Funding

IQGAP1 in tumorigenesisZIACL080017 · CLC · CLINICAL CENTER · PI SACKS, DAVID · 2012 to 2025
$0k
6 · The paper itself

Abstract

IQ motif-containing GTPase-activating protein 1 (IQGAP1) is a scaffold protein that interacts with numerous binding partners and thereby regulates fundamental biological processes. The functions of IQGAP1 are modulated by several mechanisms, including protein binding, self-association, subcellular localization, and phosphorylation. Proteome-wide screens have indicated that IQGAP1 is ubiquitinated, but the possible effects of this post-translational modification on its function are unknown. Here we characterized and evaluated the function of IQGAP1 ubiquitination. Using MS-based analysis in HEK293 cells, we identified six lysine residues (Lys-556, -1155, -1230, -1465, -1475, and -1528) as ubiquitination sites in IQGAP1. To elucidate the biological consequences of IQGAP1 ubiquitination, we converted each of these lysines to arginine and found that replacing two of these residues, Lys-1155 and Lys-1230, in the GAP-related domain of IQGAP1 (termed IQGAP1 GRD-2K) reduces its ubiquitination. Moreover, IQGAP1 GRD-2K bound a significantly greater proportion of the two Rho GTPases cell division cycle 42 (CDC42) and Rac family small GTPase 1 (RAC1) than did WT IQGAP1. Consistent with this observation, reconstitution of IQGAP1-null cells with IQGAP1 GRD-2K significantly increased the amount of active CDC42 and enhanced cell migration significantly more than WT IQGAP1. Our results reveal that ubiquitination of the CDC42 regulator IQGAP1 alters its ability to bind to and activate this GTPase, leading to physiological effects. Collectively, these findings expand our view of the role of ubiquitination in cell signaling and provide additional insight into CDC42 regulation.

Indexed as

UbiquitinationArgininecdc42 GTP-Binding ProteinCell MovementHEK293 CellsHumansLysinerac1 GTP-Binding Proteinras GTPase-Activating ProteinsUbiquitinArgininecdc42 GTP-Binding ProteinCDC42 protein, humanIQ motif containing GTPase activating protein 1Lysinerac1 GTP-Binding ProteinRAC1 protein, humanras GTPase-Activating ProteinsUbiquitinCDC42cell signalingGAP-related domainIQGAP1Ras-related C3 botulinum toxin substrate 1 (Rac1)scaffold proteinsmall GTPaseubiquitylation (ubiquitination)

Identifiers

PMID32094223
PMCPMC7152761
OpenAlexW3007227805

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.